
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $193M | -- | -- | $1.53 | -- |
08/06/2025 | Q2 | $187.3M | -- | -- | $1.39 | -- |
05/09/2025 | Q1 | $180.7M | $197.1M | $0.69 | $1.38 | -$0.69 |
02/28/2025 | Q4 | $175.4M | $190.6M | -$0.55 | $1.44 | -$1.99 |
11/08/2024 | Q3 | $144.4M | $148.3M | -$1.27 | $1.09 | -$2.36 |
08/06/2024 | Q2 | $129.1M | $138M | -$0.14 | $0.95 | -$1.09 |
05/10/2024 | Q1 | $126M | $137.4M | $0.82 | $1.00 | -$0.18 |
02/29/2024 | Q4 | $124.9M | $131.7M | $0.02 | $0.86 | -$0.84 |
11/08/2023 | Q3 | -- | -- | $0.45 | $0.84 | -$0.39 |
08/09/2023 | Q2 | -- | -- | $0.29 | $0.67 | -$0.38 |
05/08/2023 | Q1 | -- | -- | $0.06 | $0.35 | -$0.29 |
03/09/2023 | Q4 | -- | -- | -$0.28 | $0.67 | -$0.95 |
11/09/2022 | Q3 | -- | -- | -$0.55 | $0.55 | -$1.10 |
08/08/2022 | Q2 | -- | -- | -$0.94 | $0.22 | -$1.16 |
05/10/2022 | Q1 | -- | -- | -$1.27 | $0.09 | -$1.36 |
03/15/2022 | Q4 | -- | -- | -$1.72 | $0.74 | -$2.46 |
11/01/2021 | Q3 | -- | -- | -$0.37 | $0.70 | -$1.07 |
08/06/2021 | Q2 | -- | -- | -$1.17 | $0.61 | -$1.78 |
05/07/2021 | Q1 | -- | -- | $0.01 | $0.71 | -$0.70 |
03/09/2021 | Q4 | -- | -- | -$0.30 | $0.94 | -$1.24 |
11/05/2020 | Q3 | -- | -- | $0.04 | $0.88 | -$0.84 |
08/06/2020 | Q2 | -- | -- | -$1.03 | $0.75 | -$1.78 |
05/07/2020 | Q1 | -- | -- | -$0.59 | $0.89 | -$1.48 |
02/27/2020 | Q4 | -- | -- | -$0.41 | $1.18 | -$1.59 |
11/06/2019 | Q3 | -- | -- | $0.32 | $1.43 | -$1.11 |
08/07/2019 | Q2 | -- | -- | -- | $1.29 | -- |
05/09/2019 | Q1 | -- | -- | -- | $1.05 | -- |
02/27/2019 | Q4 | -- | -- | -- | $1.24 | -- |
11/06/2018 | Q3 | -- | -- | -- | $1.17 | -- |
08/07/2018 | Q2 | -- | -- | -- | -- | -- |
05/08/2018 | Q1 | -- | -- | -- | -- | -- |
02/27/2018 | Q4 | -- | -- | -- | -- | -- |
11/02/2017 | Q3 | -- | -- | -- | -- | -- |
08/03/2017 | Q2 | -- | -- | -- | -- | -- |
05/04/2017 | Q1 | -- | -- | -- | -- | -- |
03/02/2017 | Q4 | -- | -- | -- | -- | -- |
11/03/2016 | Q3 | -- | -- | -- | -- | -- |
08/04/2016 | Q2 | -- | -- | -- | -- | -- |
05/05/2016 | Q1 | -- | -- | -- | -- | -- |
02/23/2016 | Q4 | -- | -- | -- | -- | -- |
11/03/2015 | Q3 | -- | -- | -- | -- | -- |
ANI Pharmaceuticals reported $197.1M worth of top line sales in its most recent quarter.
ANI Pharmaceuticals announced earnings per share of $0.69 which represents a miss of analyst forecast a $1.38 per share.
ANI Pharmaceuticals reported $124.1M that represents $6.19 per share over the last quarter.
ANI Pharmaceuticals's earnings are forecast to grow from -$1.04 per share to $5.01 per share next year representing an increase of 489.02%.
ANI Pharmaceuticals's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.